<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03425045</url>
  </required_header>
  <id_info>
    <org_study_id>FNO-ENT-tinnitus</org_study_id>
    <secondary_id>MH CZ-DRO (FNOs/2015)</secondary_id>
    <nct_id>NCT03425045</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation for Chronic Subjective Tinnitus</brief_title>
  <official_title>Repetitive Transcranial Magnetic Stimulation for Chronic Subjective Non-Pulsatile Primary Tinnitus Compared to Placebo and Medicament Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Therapy of subjective chronic primary tinnitus could be challenging. Repetitive transcranial
      magnetic stimulation (rTMS) is currently being tested for suppressing the symptoms. However,
      effect of stimulation remains controversial. The aim was to uncover real effect of rTMS
      stimulation for tinnitus treatment. There will be three groups, stimulation group, sham
      stimulation group and controlled group with medicament treatment. The investigators assume
      that combination of rTMS stimulation of dorsolateral prefrontal cortex and primary auditory
      cortex at both sides will be more efficient. The investigators considered a 10% improvement
      in the tinnitus questionnaire score and in the tinnitus masking to be clinically relevant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adult patients suffering from chronic subjective non-pulsatile primary unilateral or
      bilateral tinnitus for at least 6 months will be included in the study. Patients will be
      randomly assigned using a random number generation randomization method into rTMS stimulation
      group (group 1), sham stimulation group (group 2) and group with medicament therapy only
      (group 3). Dorsolateral prefrontal cortex (frequency 25 Hz; 300 pulses; 80% resting motor
      threshold=RMT) and primary auditory cortex on both sides (1 Hz; 1000 pulses; 110% RMT) will
      be stimulated in patients in rTMS stimulation group for 5 consecutive days. Both the patients
      and outcome assessor were blinded to the intervention group in which the patients (rTMS and
      shame stimulation group) belonged to. Medicament therapy in group 3 will consist of ginkgo
      biloba extract EGb 761 once a day for 6 months. There will be no medicament therapy for
      tinnitus in group 1 and 2. Tinnitus reaction questionnaire (TRQ), tinnitus handicap
      questionnaire (THQ), tinnitus handicap inventory (THI), Beck Depression Inventory (BDI),
      pure-tone audiometry with Fowler scoring of hearing loss and tinnitus analysis will be used
      for evaluation of tinnitus in all patients. Data will be recorded on the day patient is
      included in the study, during follow-up after 1 month and 6 months. Descriptive statistics,
      such as the arithmetic mean, standard deviation, and absolute and relative frequency tables,
      will be used for data processing. The Pearson's chi-squared test, Fisher's exact test,
      Kruskal-Wallis test and analysis of variance will be used for comparison. The statistical
      tests will be assessed using a significance level of 5%.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2015</start_date>
  <completion_date type="Anticipated">March 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study is designed as interventional, blinded, randomized, controlled trial with three parallel arms</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The study subjects and outcomes assessors will be masked, the investigator will know which treatment is being provided for which patient.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Tinnitus Reaction Questionnaire (TRQ)</measure>
    <time_frame>36 months</time_frame>
    <description>This questionnaire will be used to find out what sort of effects tinnitus has had on the lifestyle and general well-being of the patients. 10% improvement will be considered clinically relevant.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tinnitus Handicap Questionnaire (THQ)</measure>
    <time_frame>36 months</time_frame>
    <description>This questionnaire has 27 questions and will be used to assess the degree of handicap that the tinnitus presents for the affected patients. 10% improvement will be considered clinically relevant.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tinnitus Handicap Inventory (THI)</measure>
    <time_frame>36 months</time_frame>
    <description>The purpose of this questionnaire is to identify difficulties the affected patients may be experiencing because of tinnitus. 10% improvement of the score will be considered clinically relevant.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of depression - Beck Depression Inventory</measure>
    <time_frame>36 months</time_frame>
    <description>Improvement of depressive symptoms in patients will be assessed using the Beck Depression Inventory (BDI) test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of hearing loss - Fowler scoring</measure>
    <time_frame>36 months</time_frame>
    <description>Improvement of the hearing loss in patients will be assessed using the pure-tone audiometry with Fowler scoring of hearing loss (%).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Tinnitus, Subjective</condition>
  <arm_group>
    <arm_group_label>Repetitive Transcranial Magnetic Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this study arm will undergo the rTMS stimulation as described above.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients in this study arm will undergo the sham stimulation as described above.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ginkgo Biloba Extract</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this study arm will receive medication therapy as described above, without any rTMS or sham procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Repetitive Transcranial Magnetic Stimulation</intervention_name>
    <description>Patients randomised in Arm 1 will receive stimulation of the dorsolateral prefrontal cortex (frequency 25 Hz; 300 pulses; 80% resting motor threshold=RMT) and primary auditory cortex on both sides (1 Hz; 1000 pulses; 110% RMT) will be stimulated in patients in rTMS stimulation group for 5 consecutive days. No medication therapy will be provided for patients in this arm.</description>
    <arm_group_label>Repetitive Transcranial Magnetic Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham stimulation</intervention_name>
    <description>Sham stimulation will be performed in patients randomised in Arm 2 of the study for 5 consecutive days. No medication therapy will be provided for patients in this arm.</description>
    <arm_group_label>Sham stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginkgo Biloba Extract</intervention_name>
    <description>Patients randomised in Arm 3 of the study will receive medication therapy with Ginkgo biloba extract EGb 761 once a day for 6 months.</description>
    <arm_group_label>Ginkgo Biloba Extract</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - subjective chronic non-pulsatile tinnitus lasting more than 6 months

        Exclusion Criteria:

          -  head injury or brain surgery

          -  epilepsy

          -  organic brain lesion

          -  Meniere's disease or fluctuating hearing loss

          -  cochlear or bone-anchored hearing device implantation

          -  history of suicide

          -  pregnancy

          -  therapy with anticonvulsants

          -  antipsychotic medication

          -  heart pacemaker implantation

          -  rTMS performed in the past

          -  not signing of the informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michal Bar, Ass.Prof.,MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>70852</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <link>
    <url>http://www.audiology.org</url>
    <description>The American Academy of Audiology is the world's largest professional organization of, by, and for audiologists.</description>
  </link>
  <link>
    <url>http://www.hear-it.org</url>
    <description>The world's #1 website on hearing and hearing loss, since 1999.</description>
  </link>
  <reference>
    <citation>Folmer RL, Carroll JR, Rahim A, Shi Y, Hal Martin W. Effects of repetitive transcranial magnetic stimulation (rTMS) on chronic tinnitus. Acta Otolaryngol Suppl. 2006 Dec;(556):96-101.</citation>
    <PMID>17114152</PMID>
  </reference>
  <reference>
    <citation>Oberman L, Edwards D, Eldaief M, Pascual-Leone A. Safety of theta burst transcranial magnetic stimulation: a systematic review of the literature. J Clin Neurophysiol. 2011 Feb;28(1):67-74. doi: 10.1097/WNP.0b013e318205135f. Review.</citation>
    <PMID>21221011</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipović SR, Hummel FC, Jääskeläinen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schönfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014 Nov;125(11):2150-206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5. Review.</citation>
    <PMID>25034472</PMID>
  </reference>
  <reference>
    <citation>Kim BG, Kim DY, Kim SK, Kim JM, Baek SH, Moon IS. Comparison of the outcomes of repetitive transcranial magnetic stimulation to the ipsilateral and contralateral auditory cortex in unilateral tinnitus. Electromagn Biol Med. 2014 Sep;33(3):211-5. doi: 10.3109/15368378.2013.801353. Epub 2013 Jun 19.</citation>
    <PMID>23781982</PMID>
  </reference>
  <reference>
    <citation>Kleinjung T, Eichhammer P, Landgrebe M, Sand P, Hajak G, Steffens T, Strutz J, Langguth B. Combined temporal and prefrontal transcranial magnetic stimulation for tinnitus treatment: a pilot study. Otolaryngol Head Neck Surg. 2008 Apr;138(4):497-501. doi: 10.1016/j.otohns.2007.12.022.</citation>
    <PMID>18359361</PMID>
  </reference>
  <reference>
    <citation>Kreuzer PM, Landgrebe M, Schecklmann M, Poeppl TB, Vielsmeier V, Hajak G, Kleinjung T, Langguth B. Can Temporal Repetitive Transcranial Magnetic Stimulation be Enhanced by Targeting Affective Components of Tinnitus with Frontal rTMS? A Randomized Controlled Pilot Trial. Front Syst Neurosci. 2011 Nov 4;5:88. doi: 10.3389/fnsys.2011.00088. eCollection 2011.</citation>
    <PMID>22069382</PMID>
  </reference>
  <reference>
    <citation>De Ridder D, Song JJ, Vanneste S. Frontal cortex TMS for tinnitus. Brain Stimul. 2013 May;6(3):355-62. doi: 10.1016/j.brs.2012.07.002. Epub 2012 Jul 24.</citation>
    <PMID>22853891</PMID>
  </reference>
  <reference>
    <citation>Lehner A, Schecklmann M, Kreuzer PM, Poeppl TB, Rupprecht R, Langguth B. Comparing single-site with multisite rTMS for the treatment of chronic tinnitus - clinical effects and neuroscientific insights: study protocol for a randomized controlled trial. Trials. 2013 Aug 23;14:269. doi: 10.1186/1745-6215-14-269. Erratum in: Trials. 2014;5:148.</citation>
    <PMID>23968498</PMID>
  </reference>
  <reference>
    <citation>Lehner A, Schecklmann M, Poeppl TB, Kreuzer PM, Vielsmeier V, Rupprecht R, Landgrebe M, Langguth B. Multisite rTMS for the treatment of chronic tinnitus: stimulation of the cortical tinnitus network--a pilot study. Brain Topogr. 2013 Jul;26(3):501-10. doi: 10.1007/s10548-012-0268-4. Epub 2012 Dec 11.</citation>
    <PMID>23229756</PMID>
  </reference>
  <reference>
    <citation>Langguth B, Landgrebe M, Frank E, Schecklmann M, Sand PG, Vielsmeier V, Hajak G, Kleinjung T. Efficacy of different protocols of transcranial magnetic stimulation for the treatment of tinnitus: Pooled analysis of two randomized controlled studies. World J Biol Psychiatry. 2014 May;15(4):276-85. doi: 10.3109/15622975.2012.708438. Epub 2012 Aug 22.</citation>
    <PMID>22909265</PMID>
  </reference>
  <reference>
    <citation>Hoekstra CE, Versnel H, Neggers SF, Niesten ME, van Zanten GA. Bilateral low-frequency repetitive transcranial magnetic stimulation of the auditory cortex in tinnitus patients is not effective: a randomised controlled trial. Audiol Neurootol. 2013;18(6):362-73. doi: 10.1159/000354977. Epub 2013 Oct 19.</citation>
    <PMID>24157459</PMID>
  </reference>
  <reference>
    <citation>Engelhardt J, Dauman R, Arné P, Allard M, Dauman N, Branchard O, Perez P, Germain C, Caire F, Bonnard D, Cuny E. Effect of chronic cortical stimulation on chronic severe tinnitus: a prospective randomized double-blind cross-over trial and long-term follow up. Brain Stimul. 2014 Sep-Oct;7(5):694-700. doi: 10.1016/j.brs.2014.05.008. Epub 2014 Jun 4.</citation>
    <PMID>25017670</PMID>
  </reference>
  <reference>
    <citation>Plewnia C, Vonthein R, Wasserka B, Arfeller C, Naumann A, Schraven SP, Plontke SK. Treatment of chronic tinnitus with θ burst stimulation: a randomized controlled trial. Neurology. 2012 May 22;78(21):1628-34. doi: 10.1212/WNL.0b013e3182574ef9. Epub 2012 Apr 25.</citation>
    <PMID>22539568</PMID>
  </reference>
  <reference>
    <citation>Roland LT, Peelle JE, Kallogjeri D, Nicklaus J, Piccirillo JF. The effect of noninvasive brain stimulation on neural connectivity in Tinnitus: A randomized trial. Laryngoscope. 2016 May;126(5):1201-6. doi: 10.1002/lary.25650. Epub 2015 Sep 30.</citation>
    <PMID>26422238</PMID>
  </reference>
  <reference>
    <citation>Kleinjung T, Steffens T, Sand P, Murthum T, Hajak G, Strutz J, Langguth B, Eichhammer P. Which tinnitus patients benefit from transcranial magnetic stimulation? Otolaryngol Head Neck Surg. 2007 Oct;137(4):589-95.</citation>
    <PMID>17903575</PMID>
  </reference>
  <reference>
    <citation>Khedr EM, Rothwell JC, Ahmed MA, El-Atar A. Effect of daily repetitive transcranial magnetic stimulation for treatment of tinnitus: comparison of different stimulus frequencies. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):212-5. doi: 10.1136/jnnp.2007.127712.</citation>
    <PMID>18202212</PMID>
  </reference>
  <reference>
    <citation>Marcondes RA, Sanchez TG, Kii MA, Ono CR, Buchpiguel CA, Langguth B, Marcolin MA. Repetitive transcranial magnetic stimulation improve tinnitus in normal hearing patients: a double-blind controlled, clinical and neuroimaging outcome study. Eur J Neurol. 2010 Jan;17(1):38-44. doi: 10.1111/j.1468-1331.2009.02730.x. Epub 2009 Jul 9.</citation>
    <PMID>19614962</PMID>
  </reference>
  <reference>
    <citation>Frank G, Kleinjung T, Landgrebe M, Vielsmeier V, Steffenhagen C, Burger J, Frank E, Vollberg G, Hajak G, Langguth B. Left temporal low-frequency rTMS for the treatment of tinnitus: clinical predictors of treatment outcome--a retrospective study. Eur J Neurol. 2010 Jul;17(7):951-6. doi: 10.1111/j.1468-1331.2010.02956.x. Epub 2010 Feb 10.</citation>
    <PMID>20158510</PMID>
  </reference>
  <reference>
    <citation>Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1996 Feb;122(2):143-8.</citation>
    <PMID>8630207</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2018</study_first_submitted>
  <study_first_submitted_qc>February 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2018</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic tinnitus</keyword>
  <keyword>repetitive transcranial magnetic stimulation</keyword>
  <keyword>hypacusion</keyword>
  <keyword>depression</keyword>
  <keyword>treatment</keyword>
  <keyword>placebo</keyword>
  <keyword>medication therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The plan to share IPD to other researchers has not been decided yet.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

